Cargando…
Potential Advantages of Interprofessional Care in Rheumatoid Arthritis
BACKGROUND: Rheumatoid arthritis (RA) affects over 1 million people in the United States. Although the emergence of new medications has substantially improved treatment options and outcomes for patients with RA, the disease is still a major cause of morbidity and mortality. In addition, significant...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437511/ https://www.ncbi.nlm.nih.gov/pubmed/22073937 http://dx.doi.org/10.18553/jmcp.2011.17.s9-b.S25 |
_version_ | 1785092541775872000 |
---|---|
author | Marion, Carrie Engen Balfe, Lisa M. |
author_facet | Marion, Carrie Engen Balfe, Lisa M. |
author_sort | Marion, Carrie Engen |
collection | PubMed |
description | BACKGROUND: Rheumatoid arthritis (RA) affects over 1 million people in the United States. Although the emergence of new medications has substantially improved treatment options and outcomes for patients with RA, the disease is still a major cause of morbidity and mortality. In addition, significant barriers to adherence characterize RA medication management. A reasonable approach to improving RA patient outcomes entails interprofessional, multidisciplinary models of care. Working with rheumatology specialists, RA multidisciplinary care teams may comprise case managers, pharmacists, physical and occupational therapists, social workers, physiatrists, orthopedists, or other health professionals. Experience and evidence have supported the value of interprofessional, coordinated care models for patients with various chronic diseases. However, potential drawbacks include the costs associated with implementation of such approaches, the extra time required for their administration, and the lack of incentives for clinicians to adopt collaborative care approaches. OBJECTIVES: To summarize the arguments and evidence for interprofessional, multidisciplinary care programs in RA. SUMMARY: Various multidisciplinary models of RA care have been described in the literature. Whereas the case for implementing such models is underscored by the chronic nature of the disease, by its comorbidities and complications, and by barriers to patient medication adherence, cost-effectiveness analyses to document benefits of coordinated interprofessional RA care are lacking. Most studies on interprofessional care in RA are relatively old and have been conducted outside of the United States. Nonetheless, the findings are still relevant and may shed light on potential avenues for the development of new models in this country. |
format | Online Article Text |
id | pubmed-10437511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-104375112023-08-21 Potential Advantages of Interprofessional Care in Rheumatoid Arthritis Marion, Carrie Engen Balfe, Lisa M. J Manag Care Pharm Cea BACKGROUND: Rheumatoid arthritis (RA) affects over 1 million people in the United States. Although the emergence of new medications has substantially improved treatment options and outcomes for patients with RA, the disease is still a major cause of morbidity and mortality. In addition, significant barriers to adherence characterize RA medication management. A reasonable approach to improving RA patient outcomes entails interprofessional, multidisciplinary models of care. Working with rheumatology specialists, RA multidisciplinary care teams may comprise case managers, pharmacists, physical and occupational therapists, social workers, physiatrists, orthopedists, or other health professionals. Experience and evidence have supported the value of interprofessional, coordinated care models for patients with various chronic diseases. However, potential drawbacks include the costs associated with implementation of such approaches, the extra time required for their administration, and the lack of incentives for clinicians to adopt collaborative care approaches. OBJECTIVES: To summarize the arguments and evidence for interprofessional, multidisciplinary care programs in RA. SUMMARY: Various multidisciplinary models of RA care have been described in the literature. Whereas the case for implementing such models is underscored by the chronic nature of the disease, by its comorbidities and complications, and by barriers to patient medication adherence, cost-effectiveness analyses to document benefits of coordinated interprofessional RA care are lacking. Most studies on interprofessional care in RA are relatively old and have been conducted outside of the United States. Nonetheless, the findings are still relevant and may shed light on potential avenues for the development of new models in this country. Academy of Managed Care Pharmacy 2011-11 /pmc/articles/PMC10437511/ /pubmed/22073937 http://dx.doi.org/10.18553/jmcp.2011.17.s9-b.S25 Text en Copyright © 2011, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cea Marion, Carrie Engen Balfe, Lisa M. Potential Advantages of Interprofessional Care in Rheumatoid Arthritis |
title | Potential Advantages of Interprofessional Care in Rheumatoid Arthritis |
title_full | Potential Advantages of Interprofessional Care in Rheumatoid Arthritis |
title_fullStr | Potential Advantages of Interprofessional Care in Rheumatoid Arthritis |
title_full_unstemmed | Potential Advantages of Interprofessional Care in Rheumatoid Arthritis |
title_short | Potential Advantages of Interprofessional Care in Rheumatoid Arthritis |
title_sort | potential advantages of interprofessional care in rheumatoid arthritis |
topic | Cea |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437511/ https://www.ncbi.nlm.nih.gov/pubmed/22073937 http://dx.doi.org/10.18553/jmcp.2011.17.s9-b.S25 |
work_keys_str_mv | AT marioncarrieengen potentialadvantagesofinterprofessionalcareinrheumatoidarthritis AT balfelisam potentialadvantagesofinterprofessionalcareinrheumatoidarthritis |